The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Allele will generate mRNA reprogrammed cGMP iPSC lines; conduct R&D to differentiate iPSC into liver cells including hepatocytes, cholangiocytes, endothelial progenitors, hepatic stellate cells, etc.; ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the biot | ...